Pharmacological interventions for the treatment of neonatal jaundice

Seminars in Neonatology

Volumn 7, Issue 2, 2002, Pages 111-119

  Dennery, Phyllis A ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Heme oxygenase; Hyperbilirubinaemia; Inhibition; Neurotoxicity; Pharmacologic agents; Uridine diphosphate glucuronyl transferase

Indexed keywords

AGAR; ALBUMIN; BILIRUBIN; BILIVERDIN; CHARCOAL; CHINESE DRUG; CLOFIBRATE; DA HUANG; GAN CAO; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HLA B27 ANTIGEN; HUANG LIN; HUANG QIN; INDOMETACIN; MESOPORPHYRIN CHROMIUM; MESOPORPHYRIN TIN; MESOPORPHYRIN ZINC; METALLOPORPHYRIN; NITRIC OXIDE; PENICILLAMINE; PHENOBARBITAL; PROTOPORPHYRIN TIN; PROTOPORPHYRIN ZINC; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG; YIN CHEN;

ALOPECIA; APLASTIC ANEMIA; BILIRUBIN METABOLISM; CANCER RISK; CLINICAL EXAMINATION; CONSTIPATION; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FATIGUE; GOODPASTURE SYNDROME; HEMOLYSIS; HUMAN; LD 50; MUSCLE CRAMP; NEWBORN JAUNDICE; NONHUMAN; PATHOPHYSIOLOGY; PHOTOTOXICITY; PRURITUS; REVIEW; STUPOR; TACHYPHYLAXIS; THROMBOCYTOPENIA; VOMITING;

EID: 0036547516     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2002.0098     Document Type: Article

References (52)

1. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity
2. Prevention of neonatal hyper-bilirubinaemia in non-human primates by Zn-protoporphyrin
3. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyper-bilirubinemia in term and near-term newborns
4. Control of severe hyperbilirubinemia in fullterm newborns with the inhibitor of bilirubin production Sn-mesoporphyrin
5. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: Studies with tin-mesoporphyrin
6. Control of hyper-bilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin
7. Mortality of metalloporphyrin-treated neonatal rats after light exposure
8. Dangerous effects of tin-protoporphyrin plus photo-irradiation on neonatal rats
9. Mechanism of induction of heme oxygenase by metalloporphyrins in primary chick embryo liver cells: Evidence against a stress-mediated response
10. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis
11. Mutagenicity and toxicity of chromyl chloride and its vapours
12. Permeability, cytotoxicity, and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells
13. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells
14. D-penicillamine, a non-bilirubin-displacing drug in neonatal jaundice
15. D-penicillamine treatment of hyperbilirubinaemia in preterm infants
16. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase
17. Heme oxygenase activity is decreased by D-penicillamine in neonates
18. D-penicillamine therapy in ABO hemolytic disease of the newborn infant
19. Goodpasture's syndrome in a patient receiving penicillamine and carbimazole
20. Penicillamine associated pulmonary hemorrhage
21. Generalized myasthenia gravis following use of D-pencillamine in Wilson's disease
22. Drugs in the aetiology of agranulocytosis and aplastic anaemia
23. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis
24. Differences in the nitric oxide/soluble guanylyl cyclase signalling pathway in the myocardium of neonatal and adult rats
25. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E→V) binding protein. Isolation of heme oxygenase-1
26. Phenobarbital-inducible gene expression in developing rat liver: Relationship to hepatocyte function
27. Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice
28. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants
29. Effect of phenobarbital on bilirubin metabolism in rat brain
30. Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage
31. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants
32. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months
33. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth
34. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: A double blind controlled study (author's transl)
35. A comparative review of the adverse effects of treatments for hyperlipidaemia
36. Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism
37. Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: Insights from models of obesity and type 2 diabetes
38. The prevalence use and harmful potential of some Chinese herbal medicines in babies and children
39. Traditional Chinese medicine and treatment of neonatal jaundice
40. Neonatal jaundice - Traditional Chinese medicine approach
41. An old traditional herbal remedy for eonatal jaundice with a newly identified risk
42. Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat
43. The reversal of bilirubin-induced intestinal secretion by agar
44. A new tactic for the treatment of jaundice: An injectable polymer-conjugated Bilirubin oxidase
45. Simulation of bilirubin detoxification in the newborn using an extracorporeal bilirubin oxidase reactor
46. A new enzyme 'bilirubin oxidase' produced by Murothecium verrucarea MT-1
47. Unbound bilirubin and kernicterus in low-birth-weight infants
48. Bilirubin and serial brainstem responses in premature infants
49. Variance in albumin loading in exchange transfusion
50. Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinemia
51. Bilirubin-displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants
52. Indomethacin and bilirubin-albumin binding